Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Nature | Oct 2, 2011

Recurrent chromosomal translocations involving the mixed lineage leukaemia (MLL) gene initiate aggressive forms of leukaemia, which are often refractory to conventional therapies. Many MLL-fusion partners are members of the super elongation complex (SEC), a critical regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukaemia induction. Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC and the polymerase-associated factor complex (PAFc), are associated with the BET family of acetyl-lysine recognizing, chromatin 'adaptor' proteins. These data provided the basis for therapeutic intervention in MLL-fusion leukaemia, via the displacement of the BET family of proteins from chromatin. We show that a novel small molecule inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukaemic cell lines, through the induction of early cell cycle arrest and apoptosis. I-BET151 treatment in two human leukaemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes. The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin. In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukaemia. Finally, the efficacy of I-BET151 against human leukaemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential. These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukaemias.

Pubmed ID: 21964340 RIS Download

Mesh terms: Animals | Cell Line, Tumor | Chromatin | Chromatin Immunoprecipitation | Disease Models, Animal | Gene Expression Profiling | Gene Expression Regulation, Neoplastic | Heterocyclic Compounds, 4 or More Rings | Humans | Leukemia, Myeloid, Acute | Mice | Models, Molecular | Multiprotein Complexes | Myeloid-Lymphoid Leukemia Protein | Oncogene Proteins, Fusion | Protein Binding | Proteomics | Transcription Factors | Transcription, Genetic

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: Wellcome Trust, Id: 092096
  • Agency: Medical Research Council, Id: G0800784
  • Agency: Medical Research Council, Id: G116/187
  • Agency: Cancer Research UK, Id:
  • Agency: Medical Research Council, Id:
  • Agency: Wellcome Trust, Id:

Antibody Registry (Reagent, Antibodies)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Rabbit anti-BRD4 Antibody, Affinity Purified

The epitope recognized by A301-985A maps to a region between residue 1312 and 1362 of human bromodomain-containing protein 4 using the numbering given in entry NP_490597.1 human, mouse

antibody

View all literature mentions

BRD2 Antibody

BRD2 Human, Mouse

antibody

View all literature mentions

Histone H3 antibody - ChIP Grade

Histone H3 antibody - ChIP Grade c elegans/worm, mouse, rat, plant, xenopus/amphibian, chicken/bird, drosophila/arthropod, other mammalian, amoeba/protozoa, zebrafish/fish, canine, yeast/fungi, human, mouse, rat, arabidopsis thaliana, caenorhabditis elegans, chicken, dog, fruit fly (drosophila melanogaster), indian muntjac, neurospora crassa, candida albicans, rice, saccharomyces cerevisiae, schizosaccharomyces pombe, toxoplasma gondii, trypanosoma cruzi, xenopus laevis, zebrafish

antibody

View all literature mentions

Cdk9 antibody

Cdk9 antibody human, human

antibody

View all literature mentions